The trademark application ILUMIRA was filed by Shine Technologies, LLC, a Limited Liability Company (the "Applicant"). The application was published for oppositions on October 29, 2024, and still open for oppositions.
The application was filed in English (Italian was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Active pharmaceutical ingredients, isotopes and radioisotopes for medical, therapeutic and diagnostic use
Active pharmaceutical ingredients, namely lutetium-177, for medical, therapeutic and diagnostic use
Active pharmaceutical ingredients, namely non-carrier added lutetium-177
Active pharmaceutical ingredients, namely, a radioisotope for the diagnosis and treatment of oncological diseases and disorders
Active pharmaceutical ingredients, namely, a radioisotope for the purpose of increasing the effectiveness of pharmaceutical preparations in the treatment of oncological diseases.